The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer
Colorectal cancer (CRC) is ranked as the third most prevalent and the second deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, the number of CRC cases increased over the past decades and will nearly double by 2030. The lack of clear MENA guidelines for the management of patients with CRC represents a step backwards in the fight against this burden. Therefore a panel of 24 MENA experts in the field of gastrointestinal oncology developed, using a Delphi process, the first consensus recommendations for the management of patients with advanced CRC. Forty-seven different statements were formulated in the areas of epidemiology, screening, biomarkers and treatment. These recommendations will guide, standardize and unify the management of this cancer in the MENA region.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Future oncology (London, England) - 18(2022), 24 vom: 04. Aug., Seite 2733-2744 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kourie, Hampig R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical practice guidelines |
|---|
| Anmerkungen: |
Date Completed 15.07.2022 Date Revised 15.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/fon-2022-0282 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343124777 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343124777 | ||
| 003 | DE-627 | ||
| 005 | 20231226015712.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fon-2022-0282 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1143.xml |
| 035 | |a (DE-627)NLM343124777 | ||
| 035 | |a (NLM)35791837 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kourie, Hampig R |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.07.2022 | ||
| 500 | |a Date Revised 15.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Colorectal cancer (CRC) is ranked as the third most prevalent and the second deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, the number of CRC cases increased over the past decades and will nearly double by 2030. The lack of clear MENA guidelines for the management of patients with CRC represents a step backwards in the fight against this burden. Therefore a panel of 24 MENA experts in the field of gastrointestinal oncology developed, using a Delphi process, the first consensus recommendations for the management of patients with advanced CRC. Forty-seven different statements were formulated in the areas of epidemiology, screening, biomarkers and treatment. These recommendations will guide, standardize and unify the management of this cancer in the MENA region | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a MENA | |
| 650 | 4 | |a clinical practice guidelines | |
| 650 | 4 | |a colorectal cancer | |
| 650 | 4 | |a consensus | |
| 700 | 1 | |a Ibnshamsah, Fahad |e verfasserin |4 aut | |
| 700 | 1 | |a Zouein, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Naim, Nabih |e verfasserin |4 aut | |
| 700 | 1 | |a Abbasi, Salah |e verfasserin |4 aut | |
| 700 | 1 | |a Allahloubi, Nasr |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Naqqash, Manwar |e verfasserin |4 aut | |
| 700 | 1 | |a Alolayan, Ashwaq |e verfasserin |4 aut | |
| 700 | 1 | |a Alshehri, Ahmed |e verfasserin |4 aut | |
| 700 | 1 | |a Bitar, Nizar |e verfasserin |4 aut | |
| 700 | 1 | |a Bounedjar, Adda |e verfasserin |4 aut | |
| 700 | 1 | |a Farsi, Abdulaziz Al |e verfasserin |4 aut | |
| 700 | 1 | |a Shamsi, Humaid El |e verfasserin |4 aut | |
| 700 | 1 | |a Ghali, Ramy |e verfasserin |4 aut | |
| 700 | 1 | |a Jaafar, Hassan |e verfasserin |4 aut | |
| 700 | 1 | |a Larbaoui, Blaha |e verfasserin |4 aut | |
| 700 | 1 | |a Mahrous, Mervat |e verfasserin |4 aut | |
| 700 | 1 | |a Mrabti, Hind |e verfasserin |4 aut | |
| 700 | 1 | |a Nweir, Abdul Razzak |e verfasserin |4 aut | |
| 700 | 1 | |a Oukkal, Mohamed |e verfasserin |4 aut | |
| 700 | 1 | |a Rasul, Kakil |e verfasserin |4 aut | |
| 700 | 1 | |a Razavi, Mohsen |e verfasserin |4 aut | |
| 700 | 1 | |a Turfa, Rim |e verfasserin |4 aut | |
| 700 | 1 | |a Khatib, Sami |e verfasserin |4 aut | |
| 700 | 1 | |a Shamseddine, Ali |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future oncology (London, England) |d 2005 |g 18(2022), 24 vom: 04. Aug., Seite 2733-2744 |w (DE-627)NLM161450725 |x 1744-8301 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2022 |g number:24 |g day:04 |g month:08 |g pages:2733-2744 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/fon-2022-0282 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2022 |e 24 |b 04 |c 08 |h 2733-2744 | ||